Advanced Medical Solutions Group (LON:AMS) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Advanced Medical Solutions Group plc (LON:AMS)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 216.47 and traded as low as GBX 215. Advanced Medical Solutions Group shares last traded at GBX 218, with a volume of 940,668 shares.

Wall Street Analyst Weigh In

Several research analysts have issued reports on AMS shares. Berenberg Bank reiterated a “buy” rating and issued a GBX 300 price target on shares of Advanced Medical Solutions Group in a report on Tuesday, May 19th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a GBX 260 price target on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The company has a debt-to-equity ratio of 31.50, a current ratio of 2.79 and a quick ratio of 4.58. The stock has a fifty day moving average price of GBX 221.68 and a two-hundred day moving average price of GBX 216.47. The company has a market cap of £475.04 million, a P/E ratio of 48.45, a price-to-earnings-growth ratio of 5.00 and a beta of 0.72.

Advanced Medical Solutions Group (LON:AMS) last posted its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. On average, research analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.